Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2003
09/04/2003US20030165478 Stabilized synthetic immunogen delivery system
09/04/2003US20030165444 Lipochroman-6 as no-synthase inhibitor and uses
09/04/2003US20030165434 Delivery of polynucleotide agents to the central nervous system
09/04/2003CA2479812A1 Glutaminyl based dpiv inhibitors
09/04/2003CA2477726A1 Use of tyrosine kinase inhibitors for treating substance use disorders
09/04/2003CA2477634A1 Crystalline anhydrous and monohydrate benzoate salts of (2's,3s)-3-hydroxy-n-{2{n-methyl-n-4-(n-propylamino-carbonyl)phenyl]amino-2-phenyl}-ethylpyrrolidine
09/04/2003CA2477607A1 Substituted hydroxyethylamines
09/04/2003CA2477253A1 Compositions and method for regulation of calcium-dependent signalling in brain
09/04/2003CA2477245A1 Bipolar trans carotenoid salts and their uses
09/04/2003CA2477218A1 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
09/04/2003CA2477178A1 Administration of agents for the treatment of inflammation
09/04/2003CA2477111A1 Use of tyrosine kinase inhibitors for treating cns disorders
09/04/2003CA2477105A1 Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
09/04/2003CA2477008A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003CA2476896A1 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
09/04/2003CA2476765A1 Methods of preventing or treating brain ischemia or brain injury
09/04/2003CA2476723A1 Preparation of paroxetine involving novel intermediates
09/04/2003CA2476630A1 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof
09/04/2003CA2476518A1 Compositions and methods for the treatment of immune related diseases
09/04/2003CA2476316A1 Beta3-adrenergic receptor agonists
09/04/2003CA2476173A1 Arylsulfone derivatives
09/04/2003CA2475773A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
09/04/2003CA2475655A1 Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
09/04/2003CA2475653A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
09/04/2003CA2475598A1 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide
09/04/2003CA2474793A1 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases
09/04/2003CA2459155A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
09/04/2003CA2444940A1 Process for the production of citalopram
09/03/2003EP1340979A2 Neuropeptide receptor and uses thereof
09/03/2003EP1340761A1 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)one derivatives
09/03/2003EP1340760A1 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)one derivatives
09/03/2003EP1340759A1 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives
09/03/2003EP1340758A1 Heteroaryl substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)one derivatives
09/03/2003EP1340754A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
09/03/2003EP1340748A1 Quinazoline derivatives and drugs
09/03/2003EP1340502A2 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
09/03/2003EP1340499A1 Nootropic effect enhancer
09/03/2003EP1340498A1 Use of epothilones in the treatment of brain diseases associated with proliferative processes
09/03/2003EP1340492A1 Aerosol formulations for pulmonary administration of medicaments having systemic effects
09/03/2003EP1339879A2 Method of identifying a polymorphism in cyp2d6
09/03/2003EP1339854A2 Lipid metabolism enzymes
09/03/2003EP1339840A2 Schizophrenia-related voltage-gated ion channel gene and protein
09/03/2003EP1339836A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
09/03/2003EP1339834A2 Enzymes
09/03/2003EP1339751A2 Recombinant antibody fragments as autoantibody antagonists
09/03/2003EP1339748A2 G-protein coupled receptors
09/03/2003EP1339737A2 Immunomodulatory protein derived from the yaba monkey tumor virus
09/03/2003EP1339721A2 Hydroxyesters of 7-desmethylrapamycin
09/03/2003EP1339719A1 Benzimidazole derivatives, preparation and therapeutic use thereof
09/03/2003EP1339717A1 Novel carbamate-substituted pyrazolopyridine derivatives
09/03/2003EP1339716A1 Novel lactame-substituted pyrazolopyridine derivatives
09/03/2003EP1339715A2 Heterocyclic ether substituted imidazoquinolines
09/03/2003EP1339714A1 Novel sulfonamide-substituted pyrazolopyridine derivatives
09/03/2003EP1339712A1 3-substituted quinuclidines and their use as nicotinic agonists
09/03/2003EP1339711A1 Aminothiazoles and their use as adenosine receptor antagonists
09/03/2003EP1339710A1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives
09/03/2003EP1339709A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives
09/03/2003EP1339708A2 Indole-type inhibitors of p38 kinase
09/03/2003EP1339706A1 N-type calcium channel antagonists for the treatment of pain
09/03/2003EP1339698A2 Pyrimidine derivatives
09/03/2003EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands
09/03/2003EP1339694A1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists
09/03/2003EP1339691A1 Novel compounds
09/03/2003EP1339690A1 N-type calcium channel antagonists for the treatment of pain
09/03/2003EP1339688A1 N-type calcium channel antagonists for the treatment of pain
09/03/2003EP1339680A1 Substituted oxindole derivatives as tyrosine kinase inhibitors
09/03/2003EP1339679A1 3-arylindole derivatives and their use as cb2 receptor agonists
09/03/2003EP1339677A1 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis
09/03/2003EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
09/03/2003EP1339669A2 N-alkylated gaba compounds, processes for their preparation and their use as medicaments
09/03/2003EP1339668A2 Bisubstituted carbocyclic cyclophilin binding compounds and theirus
09/03/2003EP1339663A2 Naphthalene derivatives
09/03/2003EP1339662A1 Novel estrogen receptor ligands and methods iii
09/03/2003EP1339458A2 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity
09/03/2003EP1339424A2 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors
09/03/2003EP1339411A2 Use of bisphosphonates for pain treatment
09/03/2003EP1339410A1 Use of pyrazolo 4,3-d]pyrimidines
09/03/2003EP1339406A2 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders
09/03/2003EP1339404A2 Composition and method
09/03/2003EP1339403A2 Repinotan kit
09/03/2003EP1339402A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
09/03/2003EP1339398A2 Treatment of motor fluctuations with 5-hydroxytryptamine 1a receptor activity enhancing compounds
09/03/2003EP1235826B1 Quinuclidine acrylamides
09/03/2003EP1196414B1 Prodrugs of carbamate inhibitors of impdh
09/03/2003EP1158992B1 Use of xenon for preparing a pharmaceutical preparation for treating neurointoxications
09/03/2003EP1140048B1 Use of naaladase inhibitors for the manufacture of a medicament for the treatment of certain diseases
09/03/2003EP1133295B1 Use of nicergoline for treating spasmodism
09/03/2003EP1095038B1 Antagonists of gonadotropin releasing hormone
09/03/2003EP1070065B1 Azabicyclic 5ht1 receptor ligands
09/03/2003EP1066287B1 Azatricyclic compounds
09/03/2003EP1060178B1 Heterocyclic compounds as inhibitors of rotamase enzymes
09/03/2003EP0973792B1 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
09/03/2003EP0934271B1 Substituted arylalkylamines as neurokinin antagonists
09/03/2003EP0914614B1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrPsc
09/03/2003EP0910372B1 Pharmaceutical compositions containing mesembrine and related compounds
09/03/2003EP0833612B1 New pharmaceutical composition with anaesthetic effect
09/03/2003EP0797435B1 Controlled release matrix for pharmaceuticals
09/03/2003EP0612318B1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
09/03/2003CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof
09/03/2003CN1440420A Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
1 ... 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 ... 1833